ARTICLE | Distillery Therapeutics
Autoimmune
December 19, 2017 8:58 PM UTC
Cell culture and mouse studies suggest inhibiting Bcl-XL could help treat scleroderma. In primary human dermal fibroblasts cultured on a stiff matrix to mimic fibrotic conditions, siRNA targeting Bcl-...
BCIQ Company Profiles
BCIQ Target Profiles